Cargando…

Effect of tofacitinib therapy on angiotensin converting enzyme activity in rheumatoid arthritis

INTRODUCTION: The Renin-Angiotensin-Aldosterone system (RAAS) has been implicated in the regulation of the cardiovascular system and linked to rheumatoid arthritis (RA). Little information has become available on the effects of Janus kinase (JAK) inhibition on RAAS. Here we studied the effects of 12...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kacsándi, Dorottya, Fagyas, Miklós, Horváth, Ágnes, Végh, Edit, Pusztai, Anita, Czókolyová, Monika, Soós, Boglárka, Szabó, Attila Ádám, Hamar, Attila, Pethő, Zsófia, Bodnár, Nóra, Kerekes, György, Hodosi, Katalin, Szamosi, Szilvia, Szűcs, Gabriella, Papp, Zoltán, Szekanecz, Zoltán
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591318/ https://www.ncbi.nlm.nih.gov/pubmed/37877017 http://dx.doi.org/10.3389/fmed.2023.1226760

Ejemplares similares

Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients
por: Soós, Boglárka, et al.
Publicado: (2022)

Prospective, simultaneous assessment of joint and vascular inflammation by PET/CT in tofacitinib-treated patients with rheumatoid arthritis: associations with vascular and bone status
por: Hamar, Attila, et al.
Publicado: (2021)

Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis
por: Kerekes, György, et al.
Publicado: (2023)

Effects of tofacitinib therapy on arginine and methionine metabolites in association with vascular pathophysiology in rheumatoid arthritis: A metabolomic approach
por: Soós, Boglárka, et al.
Publicado: (2022)

Effects of One-Year Tofacitinib Therapy on Lipids and Adipokines in Association with Vascular Pathophysiology in Rheumatoid Arthritis
por: Czókolyová, Monika, et al.
Publicado: (2022)

Complex assessment of bone mineral density, fracture risk, vitamin D status, and bone metabolism in Hungarian systemic sclerosis patients
por: Horváth, Ágnes, et al.
Publicado: (2019)

Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis
por: Hamar, A., et al.
Publicado: (2021)

Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology
por: Czókolyová, Monika, et al.
Publicado: (2021)

Associations of vascular and bone status in arthritis patients
por: Pusztai, Anita, et al.
Publicado: (2021)

Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis
por: Póliska, Szilárd, et al.
Publicado: (2019)

Peripheral quantitative computed tomography in the assessment of bone mineral density in anti-TNF-treated rheumatoid arthritis and ankylosing spondylitis patients
por: Juhász, Balázs, et al.
Publicado: (2021)

Effect of Fcγ-receptor 3a (FCGR3A) gene polymorphisms on rituximab therapy in Hungarian patients with rheumatoid arthritis
por: Pál, Ildikó, et al.
Publicado: (2017)

Characterization of bone metabolism in hungarian psoriatic arthritis patients: a case–control study
por: Pethő, Zsófia, et al.
Publicado: (2021)

Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis - a prospective case-series study
por: Timár, Orsolya, et al.
Publicado: (2013)

Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals
por: Szekanecz, Zoltán, et al.
Publicado: (2023)

Salivary citrullinated proteins in rheumatoid arthritis and associated periodontal disease
por: Tar, Ildikó, et al.
Publicado: (2021)

Assessment of intracranial vessels in association with carotid atherosclerosis and brain vascular lesions in rheumatoid arthritis
por: Oláh, Csaba, et al.
Publicado: (2017)

Severity and prognostic factors of SARS-CoV-2-induced pneumonia: The value of clinical and laboratory biomarkers and the A-DROP score
por: Szabó, Miklós, et al.
Publicado: (2022)

Bioactivity-Guided Isolation of Antimicrobial and Antioxidant Metabolites from the Mushroom Tapinella atrotomentosa
por: Béni, Zoltán, et al.
Publicado: (2018)

Assessing the risk of rapid radiographic progression in Hungarian rheumatoid arthritis patients
por: Végh, Edit, et al.
Publicado: (2021)

Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients
por: Fagyas, Miklós, et al.
Publicado: (2022)

Circulating ACE2 activity correlates with cardiovascular disease development
por: Úri, Katalin, et al.
Publicado: (2016)

Common mechanisms and holistic care in atherosclerosis and osteoporosis
por: Szekanecz, Zoltán, et al.
Publicado: (2019)

A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient
por: Nagy, Béla, et al.
Publicado: (2021)

Immune-related adverse events of anti-PD-1 immune checkpoint inhibitors: a single center experience
por: Sebestyén, Enikő, et al.
Publicado: (2023)

New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) IV: Circulating ACE2 as a Biomarker of Systolic Dysfunction in Human Hypertension and Heart Failure
por: Úri, Katalin, et al.
Publicado: (2014)

New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) I: Endogenous Angiotensin Converting Enzyme (ACE) Inhibition
por: Fagyas, Miklós, et al.
Publicado: (2014)

New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) III: Endogenous Inhibition of Angiotensin Converting Enzyme (ACE) Provides Protection against Cardiovascular Diseases
por: Fagyas, Miklós, et al.
Publicado: (2014)

Level of the SARS-CoV-2 receptor ACE2 activity is highly elevated in old-aged patients with aortic stenosis: implications for ACE2 as a biomarker for the severity of COVID-19
por: Fagyas, Miklós, et al.
Publicado: (2021)

The majority of severe COVID-19 patients develop anti-cardiac autoantibodies
por: Fagyas, Miklós, et al.
Publicado: (2022)

Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
por: Oláh, Attila, et al.
Publicado: (2017)

Single acute stress-induced progesterone and ovariectomy alter cardiomyocyte contractile function in female rats
por: Kalász, Judit, et al.
Publicado: (2014)

Alterations in ACE and ACE2 Activities and Cardiomyocyte Signaling Underlie Improved Myocardial Function in a Rat Model of Repeated Remote Ischemic Conditioning
por: Bódi, Beáta, et al.
Publicado: (2021)

The value of transcranial Doppler monitoring of cerebral blood flow changes during carotid endarterectomy performed under regional anesthesia – A case series
por: Gyöngyösi, Zoltán, et al.
Publicado: (2022)

Sex-specific chronic stress response at the level of adrenal gland modifies sexual hormone and leptin receptors
por: Balog, Marta, et al.
Publicado: (2015)

Human Tissue Angiotensin Converting Enzyme (ACE) Activity Is Regulated by Genetic Polymorphisms, Posttranslational Modifications, Endogenous Inhibitors and Secretion in the Serum, Lungs and Heart
por: Bánhegyi, Viktor, et al.
Publicado: (2021)

Tenascin‐C aggravates ventricular dilatation and angiotensin‐converting enzyme activity after myocardial infarction in mice
por: Santer, David, et al.
Publicado: (2020)

Determinants of biological drug survival in rheumatoid arthritis: evidence from a Hungarian rheumatology center over 8 years of retrospective data
por: Brodszky, Valentin, et al.
Publicado: (2017)

Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy
por: Lódi, Mária, et al.
Publicado: (2020)

Changes in the SARS-CoV-2 cellular receptor ACE2 levels in cardiovascular patients: a potential biomarker for the stratification of COVID-19 patients
por: Fagyas, Miklós, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8i1e7sr6hejbpiuacgs5kv4ng2